Levothyroxine Sodium Injection, Solution
Product Images NDC 63323-895

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 63323-895). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Lev19 0002 01)

Chemical structure of Levothyroxine Sodium, showing its molecular components including aromatic rings, hydroxyl groups, and the sodium salt of the amino acid moiety.*

FDA Label Image

Fresenius Logo (Lev19 0002 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)

Label for Levothyroxine Sodium injection, solution for intravenous use, 100 mcg per 5 mL (20 mcg per mL) strength. The label indicates the product is preservative-free, supplied as a 5 mL single-dose vial, and instructs to discard unused portions. The labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)

Label for Levothyroxine Sodium Injection, solution for intravenous use, with a concentration of 20 mcg/mL, supplied as 100 mcg per 5 mL in a 5 mL single-dose vial. The label indicates it is preservative free and manufactured by Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)

Label for Levothyroxine Sodium Injection, 500 mcg per 5 mL (100 mcg per mL) intravenous injection by Fresenius Kabi USA, LLC. The label states it is preservative free, in a 5 mL single-dose vial, and instructs to discard unused portions.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)

Label for Levothyroxine Sodium injection, showing a 5 mL single-dose vial with a concentration of 100 mcg per mL (500 mcg per 5 mL). The product is preservative-free and intended for intravenous use. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Vial Label)

Label for Levothyroxine Sodium Injection, 200 mcg per 5 mL (40 mcg per mL) single-dose vial. The product is preservative free and intended for intravenous use. The vial contains 5 mL and is labeled for discard after opening. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Levothyroxine Sodium Injection 5 mL Carton Panel)

Label for Levothyroxine Sodium Injection, 200 mcg per 5 mL (40 mcg/mL) single-dose vial. Intended for intravenous use, preservative free, with instructions to discard unused portion. Label includes NDC 63323-890-10 and Fresenius Kabi USA, LLC logo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.